Cancer of unknown primary (CUP)
Results
Phase 2
This trial looked at epirubicin, cisplatin and capecitabine for cancer of unknown primary. It also looked at testing new ways to find out where the cancer started. It was supported by Cancer Research UK.
This trial was open for people to join between 2010 and 2014. The trial team first reported results at a conference in 2014, and reported further results in 2019.
Recruitment start: 1 February 2010
Recruitment end: 30 November 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Harpreet Wasan
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/08/006.
Last reviewed: 12 Oct 2020
CRUK internal database number: 823
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
